Home > News > Top Stories > Liberty HomeCare and Hospice Announces Axxess as New Healthcare Technology Partner

Health Technology

Liberty HomeCare and Hospice Announces Axxess as New Healthcare Technology Partner

Liberty HomeCare

On May 25th, premier palliative care provider Liberty HomeCare and Hospice announced a partership with healthcare technology solutions firm, Axxess. Liberty aims to enhance its clinician experience by automating documentation and other processes. The organization chose Axxess in a bid to improve employee retention and centralize its billing process.

"I didn't expect to make a software transition again in my career, but when we vetted Axxess it was an easy decision. The service and communication they have provided has been above and beyond. The clinical team and the billing and financial leaders have high regard for Axxess. We have already seen revenue growth in locations using Axxess, and more of the branches are asking to be in the next implementation wave."

Holly MacDonald, president of Liberty HomeCare and Hospice

Liberty serves to communities through its 30 locations in Virginia, North Carolina, and South Carolina. The organization has been delivering quality hospice, home care, and palliative care. It also rolled out the first phase of the Axxess platform implementation, and plans to unveil it across its other locations.  

John Olajide, founder and CEO of Axxess, added, "The partnership between Liberty and Axxess is a natural fit. Holly and the Liberty team made it clear that they wanted to work with a company that would be responsive and innovative so they can efficiently and effectively run their enterprise operations. Axxess is committed to working with our clients to deliver what they need, and we have the global presence and resources to do that every day."

Axxess is an innovator in healthcare technology and is trusted by more than 9,000 firms in the healthcare industry. The company is well known for its range of cutting-edge software that is currently used to serve over 3 million patients globally. 

MacDonald further commented, "For our clinicians, the Axxess Certification Program is going to create so many efficiencies. It will give us a standard way to get our staff properly trained. With an organization of our size, we needed a way to uniformly train our staff. When we saw this program, we immediately knew this was the solution we needed."

Spotlight

More featured news

Spotlight

Related News

Healthcare Analytics

Hartford HealthCare and Walgreens partner to provide health clinics that improve access to care

PR Newswire | October 26, 2023

Walgreens and Hartford HealthCare will add health clinics to select Walgreens locations in Connecticut, advancing a unique retail health model based on convenience, access to care, affordability and health equity. This is Walgreens first retail clinic collaboration with a health system in New England. Under a clinical collaboration agreement, five clinics operated by Hartford HealthCare medical providers will be added to Walgreens locations, including 340 Flanders Road, in East Lyme (at Flanders Four Corners); 2 Shaker Road, in Enfield; 235 Main Street, in Norwalk; and 203 Kennedy Drive, in Putnam. One additional location will be announced in the coming months. Hartford HealthCare at Walgreens clinics are scheduled to open within a year and will offer primary care, screenings, vaccinations, confidential telehealth services and more, seven days per week by appointment or walk-in. The collaboration is based on the organizations' shared vision to improve access to care, reduce healthcare costs and offer convenient access to essential primary care and pharmacy services. The locations will offer consumers a convenient destination to access both Walgreens experience in community retail health and pharmacy operations and Hartford HealthCare's expertise in delivering patient care, employing highly qualified medical professionals, and operating health centers. Hartford HealthCare at Walgreens will combine in-person care from a medical professional and, when needed, confidential in-store virtual care. For ease of access, an employee of Hartford HealthCare Medical Group will provide patient registration and point-of-care services, while a Medical Group primary care provider will offer private virtual care visits, including referrals as needed. Rounding out the experience, patients will have convenient access to Walgreens pharmacy and retail services. said Jeffrey A. Flaks, President and Chief Executive Officer of Hartford HealthCare Hartford HealthCare is intent on changing the way healthcare is delivered, and this collaboration with Walgreens is another example of the variety of convenient offerings and care settings we are adding. Our organizations are working together to combine resources and best practices to create an innovative retail health environment that meets consumers' needs and exceeds their expectations. [Source:PR Newswire] "Walgreens is committed to providing patients the care they need when and how it is most convenient for them," said John Driscoll, executive vice president and president, U.S. Healthcare, Walgreens Boots Alliance. "Through this special collaboration with Hartford HealthCare, we can help keep patients more connected to high-quality care and foster long-term relationships and behaviors that help patients get and stay healthy." Together, Walgreens and Hartford HealthCare will provide one-stop convenience — a community health destination offering a health clinic, pharmacy services and retail all in one location. Patients can see their provider, pick up their medications and go shopping at their neighborhood Wcapitalalgreens. Nearly 80% of Americans live within five miles of a Walgreens store.

Read More

Health Technology, Digital Healthcare

GE HealthCare and Novo Nordisk to Collaborate to Advance Novel Non-Invasive Treatment for Type 2 Diabetes and Obesity with Ultrasound

Business Wire | October 20, 2023

GE HealthCare announced a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity. PFUS is a non-invasive type of bioelectronic medicine that uses ultrasound to activate the nervous system to stimulate a response that may be able to treat disease. Pre-clinical proof of concept and initial early-stage clinical research suggests that it may impact glucose metabolism in people with diabetes via personalized ultrasound stimulation of nerve pathways. If validated with further clinical evidence, PFUS could represent a non-pharmacologic approach to normalize blood glucose levels in people with type 2 diabetes. The existing technology was developed by a team of scientists at GE HealthCare’s HealthCare Technology and Innovation Center, formerly part of the GE Research Center. said Roland Rott, President and CEO, Ultrasound, GE HealthCare. In an era where diabetes is increasing around the globe, we are enthusiastic about the potential for ultrasound to help people live healthier lives, This collaboration with Novo Nordisk opens a path to evolve ultrasound from a means of screening and diagnosis into therapy, as well. We are eager to validate and further develop this potentially groundbreaking science, as we strive to offer patients alternative treatment options for chronic diseases. [Source – Business Wire] An estimated 540 million adults around the world have diabetes, with type 2 diabetes accounting for more than 90 percent of cases.1 An estimated one in eight individuals will have diabetes in 2045, with significant disease burden in low-and-middle-income countries.1 Given its impact on quality of life and mortality, and with its prevalence increasing at an alarming rate for the past three decades,2 type 2 diabetes is a significant public health burden. Obesity impacts approximately 1 billion people worldwide.3 “We look forward to exploring the potential impact this technology could have on treating people with type 2 diabetes and obesity, as significant unmet needs remain in these diseases in spite of recent advances in care,” said Martin Holst Lange, Executive Vice President and Head of Development at Novo Nordisk. “Although early, the possibilities of using ultrasound for therapeutic purposes are compelling and we welcome our collaboration with GE HealthCare in this truly novel area.” As part of the collaboration, GE HealthCare and Novo Nordisk will contribute their respective expertise in ultrasound medical technology and metabolic disease treatment and management as both parties work together to develop a PFUS solution to improve patient care, building upon the extensive foundational research done to date by the GE HealthCare team. Additional terms of the agreement were not disclosed. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Read More

Health Technology

TeleVox Secures Odeza's Patient Engagement Unit from Ensemble Health

TeleVox | September 11, 2023

TeleVox and Ensemble will provide Ensemble's clients with an all-encompassing healthcare solution, from patient acquisition to post-discharge care. This announcement is yet another significant milestone in TeleVox's continuous rapid growth and expansion journey. This acquisition underscores TeleVox's commitment to strengthening its presence in the healthcare sector as it integrates Odeza's patient engagement business. TeleVox, a distinguished provider of state-of-the-art omnichannel digital patient engagement technology, has completed a significant acquisition by owning the Odeza patient engagement business from Ensemble Health Partners (Ensemble). Ensemble, recognized as a preeminent force in revenue cycle management, specializes in delivering its services to various healthcare institutions, including hospitals, health systems, and physician practices. TeleVox and Ensemble are committed to extending the reach and accessibility of TeleVox's cutting-edge technology to Ensemble's existing customer base. This strategic endeavor aims to deliver healthcare providers an all-encompassing solution that seamlessly caters to a broad spectrum of healthcare requirements, commencing with the initial patient acquisition phase and extending throughout the entirety of the patient journey. This comprehensive approach encompasses not only the discharge process but extends into subsequent phases of aftercare and beyond, equipping healthcare institutions with the essential tools and resources to optimize patient engagement, streamline operational workflows, and elevate the overall quality of care delivery. Additionally, this move positions TeleVox to enhance its capabilities further in providing innovative solutions, enabling healthcare providers to engage with patients in a more comprehensive and technologically advanced manner, ultimately advancing the healthcare industry. Vik Krishnan, President of TeleVox, expressed his welcome to Odeza joining the TeleVox family and highlighted that the acquisition of Odeza's patient engagement business aligns with TeleVox's longstanding commitment to tailored communication solutions for enhancing the patient experience, solidifying TeleVox's position as an industry leader. He also emphasized that making their patient engagement solutions accessible to Ensemble's extensive customer base will enable more healthcare providers to deliver exceptional patient care. Judson Ivy, Founder, President and CEO of Ensemble Health Partners, remarked, "This partnership strengthens each of our positions in the healthcare industry and delivers unmatched value to our customers." Meanwhile, the company unveiled Iris, an AI-powered omnichannel conversational virtual assistant tailored for healthcare providers, in April. The introduction of an automated reputation management solution in the month that followed this significant development gave hospitals, health systems, and physician practices the ability to manage and improve their online presence effectively.

Read More

Healthcare Analytics

Hartford HealthCare and Walgreens partner to provide health clinics that improve access to care

PR Newswire | October 26, 2023

Walgreens and Hartford HealthCare will add health clinics to select Walgreens locations in Connecticut, advancing a unique retail health model based on convenience, access to care, affordability and health equity. This is Walgreens first retail clinic collaboration with a health system in New England. Under a clinical collaboration agreement, five clinics operated by Hartford HealthCare medical providers will be added to Walgreens locations, including 340 Flanders Road, in East Lyme (at Flanders Four Corners); 2 Shaker Road, in Enfield; 235 Main Street, in Norwalk; and 203 Kennedy Drive, in Putnam. One additional location will be announced in the coming months. Hartford HealthCare at Walgreens clinics are scheduled to open within a year and will offer primary care, screenings, vaccinations, confidential telehealth services and more, seven days per week by appointment or walk-in. The collaboration is based on the organizations' shared vision to improve access to care, reduce healthcare costs and offer convenient access to essential primary care and pharmacy services. The locations will offer consumers a convenient destination to access both Walgreens experience in community retail health and pharmacy operations and Hartford HealthCare's expertise in delivering patient care, employing highly qualified medical professionals, and operating health centers. Hartford HealthCare at Walgreens will combine in-person care from a medical professional and, when needed, confidential in-store virtual care. For ease of access, an employee of Hartford HealthCare Medical Group will provide patient registration and point-of-care services, while a Medical Group primary care provider will offer private virtual care visits, including referrals as needed. Rounding out the experience, patients will have convenient access to Walgreens pharmacy and retail services. said Jeffrey A. Flaks, President and Chief Executive Officer of Hartford HealthCare Hartford HealthCare is intent on changing the way healthcare is delivered, and this collaboration with Walgreens is another example of the variety of convenient offerings and care settings we are adding. Our organizations are working together to combine resources and best practices to create an innovative retail health environment that meets consumers' needs and exceeds their expectations. [Source:PR Newswire] "Walgreens is committed to providing patients the care they need when and how it is most convenient for them," said John Driscoll, executive vice president and president, U.S. Healthcare, Walgreens Boots Alliance. "Through this special collaboration with Hartford HealthCare, we can help keep patients more connected to high-quality care and foster long-term relationships and behaviors that help patients get and stay healthy." Together, Walgreens and Hartford HealthCare will provide one-stop convenience — a community health destination offering a health clinic, pharmacy services and retail all in one location. Patients can see their provider, pick up their medications and go shopping at their neighborhood Wcapitalalgreens. Nearly 80% of Americans live within five miles of a Walgreens store.

Read More

Health Technology, Digital Healthcare

GE HealthCare and Novo Nordisk to Collaborate to Advance Novel Non-Invasive Treatment for Type 2 Diabetes and Obesity with Ultrasound

Business Wire | October 20, 2023

GE HealthCare announced a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity. PFUS is a non-invasive type of bioelectronic medicine that uses ultrasound to activate the nervous system to stimulate a response that may be able to treat disease. Pre-clinical proof of concept and initial early-stage clinical research suggests that it may impact glucose metabolism in people with diabetes via personalized ultrasound stimulation of nerve pathways. If validated with further clinical evidence, PFUS could represent a non-pharmacologic approach to normalize blood glucose levels in people with type 2 diabetes. The existing technology was developed by a team of scientists at GE HealthCare’s HealthCare Technology and Innovation Center, formerly part of the GE Research Center. said Roland Rott, President and CEO, Ultrasound, GE HealthCare. In an era where diabetes is increasing around the globe, we are enthusiastic about the potential for ultrasound to help people live healthier lives, This collaboration with Novo Nordisk opens a path to evolve ultrasound from a means of screening and diagnosis into therapy, as well. We are eager to validate and further develop this potentially groundbreaking science, as we strive to offer patients alternative treatment options for chronic diseases. [Source – Business Wire] An estimated 540 million adults around the world have diabetes, with type 2 diabetes accounting for more than 90 percent of cases.1 An estimated one in eight individuals will have diabetes in 2045, with significant disease burden in low-and-middle-income countries.1 Given its impact on quality of life and mortality, and with its prevalence increasing at an alarming rate for the past three decades,2 type 2 diabetes is a significant public health burden. Obesity impacts approximately 1 billion people worldwide.3 “We look forward to exploring the potential impact this technology could have on treating people with type 2 diabetes and obesity, as significant unmet needs remain in these diseases in spite of recent advances in care,” said Martin Holst Lange, Executive Vice President and Head of Development at Novo Nordisk. “Although early, the possibilities of using ultrasound for therapeutic purposes are compelling and we welcome our collaboration with GE HealthCare in this truly novel area.” As part of the collaboration, GE HealthCare and Novo Nordisk will contribute their respective expertise in ultrasound medical technology and metabolic disease treatment and management as both parties work together to develop a PFUS solution to improve patient care, building upon the extensive foundational research done to date by the GE HealthCare team. Additional terms of the agreement were not disclosed. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Read More

Health Technology

TeleVox Secures Odeza's Patient Engagement Unit from Ensemble Health

TeleVox | September 11, 2023

TeleVox and Ensemble will provide Ensemble's clients with an all-encompassing healthcare solution, from patient acquisition to post-discharge care. This announcement is yet another significant milestone in TeleVox's continuous rapid growth and expansion journey. This acquisition underscores TeleVox's commitment to strengthening its presence in the healthcare sector as it integrates Odeza's patient engagement business. TeleVox, a distinguished provider of state-of-the-art omnichannel digital patient engagement technology, has completed a significant acquisition by owning the Odeza patient engagement business from Ensemble Health Partners (Ensemble). Ensemble, recognized as a preeminent force in revenue cycle management, specializes in delivering its services to various healthcare institutions, including hospitals, health systems, and physician practices. TeleVox and Ensemble are committed to extending the reach and accessibility of TeleVox's cutting-edge technology to Ensemble's existing customer base. This strategic endeavor aims to deliver healthcare providers an all-encompassing solution that seamlessly caters to a broad spectrum of healthcare requirements, commencing with the initial patient acquisition phase and extending throughout the entirety of the patient journey. This comprehensive approach encompasses not only the discharge process but extends into subsequent phases of aftercare and beyond, equipping healthcare institutions with the essential tools and resources to optimize patient engagement, streamline operational workflows, and elevate the overall quality of care delivery. Additionally, this move positions TeleVox to enhance its capabilities further in providing innovative solutions, enabling healthcare providers to engage with patients in a more comprehensive and technologically advanced manner, ultimately advancing the healthcare industry. Vik Krishnan, President of TeleVox, expressed his welcome to Odeza joining the TeleVox family and highlighted that the acquisition of Odeza's patient engagement business aligns with TeleVox's longstanding commitment to tailored communication solutions for enhancing the patient experience, solidifying TeleVox's position as an industry leader. He also emphasized that making their patient engagement solutions accessible to Ensemble's extensive customer base will enable more healthcare providers to deliver exceptional patient care. Judson Ivy, Founder, President and CEO of Ensemble Health Partners, remarked, "This partnership strengthens each of our positions in the healthcare industry and delivers unmatched value to our customers." Meanwhile, the company unveiled Iris, an AI-powered omnichannel conversational virtual assistant tailored for healthcare providers, in April. The introduction of an automated reputation management solution in the month that followed this significant development gave hospitals, health systems, and physician practices the ability to manage and improve their online presence effectively.

Read More

More featured news